Systemic Polyarteritis Nodosa in the Young: A Single‐Center Experience Over Thirty‐Two Years
Open Access
- 10 June 2013
- journal article
- vasculitis
- Published by Wiley in Arthritis & Rheumatism
- Vol. 65 (9) , 2476-2485
Abstract
Objective: Polyarteritis nodosa (PAN) is a rare disease of childhood. The aims of this study were to describe the clinical features, treatment, and outcome of systemic childhood PAN and to identify predictors of relapse.Methods: A single‐center retrospective medical records review of children with PAN fulfilling the European League Against Rheumatism (EULAR)/Paediatric Rheumatology European Society (PRES)/Paediatric Rheumatology International Trials Organisation (PRINTO) classification criteria who were seen over a 32‐year period was performed. Data on demographic and clinical features, treatments, relapses (recurrence of clinical signs/symptoms or occurrence of new symptoms after initial remission requiring escalation or resumption of immunosuppressive therapy), and deaths were recorded. A disease activity score was retrospectively assigned using the Paediatric Vasculitis Activity Score (PVAS) instrument. Cox regression analysis was used to identify significant predictors of relapse.Results: Sixty‐nine children with PAN were identified; 55% were male, and their median age was 8.5 years (range 0.9–15.8 years). Their clinical features at presentation were fever (87%), myalgia (83%), skin (88%), renal (19%), severe gastrointestinal (GI) (10%), and neurologic (10%) involvement. The PVAS at presentation was 9 of 63 (range 4–24). Histopathologic analysis of the skin showed necrotizing vasculitis in biopsy samples from 40 of 50 children. Results of selective visceral arteriography suggested the presence of PAN in 96% of patients. Treatment included cyclophosphamide and corticosteroids (83%), plasma exchange (9%), and biologic agents (after 2002; 13%). The relapse rate was 35%, and the mortality rate was 4%. Severe GI involvement was associated with increased risk of relapse (P = 0.031), while longer time to induce remission (P = 0.022) and increased cumulative dose of cyclophosphamide (P = 0.005) were associated with lower relapse risk.Conclusion: Childhood PAN is a severe inflammatory disease of insidious onset and variable clinical presentation. Relapses occurred more frequently in those with severe GI involvement. A higher cumulative dose of cyclophosphamide was associated with a lower risk of relapse.Keywords
This publication has 29 references indexed in Scilit:
- EULAR/PRINTO/PRES criteria for Henoch–Schönlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis and childhood Takayasu arteritis: Ankara 2008. Part II: Final classification criteriaAnnals of the Rheumatic Diseases, 2010
- Medium-size-vessel vasculitisPediatric Nephrology, 2009
- Juvenile polyarteritis: Results of a multicenter survey of 110 childrenThe Journal of Pediatrics, 2004
- Renal angiography in children with polyarteritis nodosaPediatric Nephrology, 2002
- Renal involvement in polyarteritis nodosa: evaluation of 26 Turkish childrenPediatric Nephrology, 2000
- Benign cutaneous polyarteritis nodosa in children below 10 years of age–a clinical experience.Annals of the Rheumatic Diseases, 1995
- Diagnosis and Clinical Management of Childhood Vasculitic DiseaseVascular Medicine Review, 1993
- Diagnostic criteria for polyarteritis nodosa in childhoodThe Journal of Pediatrics, 1992
- Classification and Pathogenesis of Arteritis in ChildrenToxicologic Pathology, 1989
- Polyarteritis nodosa in childhoodArthritis & Rheumatism, 1979